Skip to main content
logo
Clarity Pharmaceuticals Ltd (ASX:CU6)
Australia flag Australia · Delayed Price · Currency is AUD
3.760
-0.005 (-0.13%)
Sep 29, 2025, 1:41 PM AEST

Clarity Pharmaceuticals Revenue

In the fiscal year ending June 30, 2025, Clarity Pharmaceuticals had annual revenue of 9.46M AUD, down -17.76%. Clarity Pharmaceuticals had revenue of 4.77M in the half year ending June 30, 2025, with 17.37% growth.

Revenue
9.46M
Revenue Growth
-17.76%
P/S Ratio
147.79
Revenue / Employee
n/a
Employees
69
Market Cap
1.40B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20259.46M-2.04M-17.76%
Jun 30, 202411.51M1.71M17.41%
Jun 30, 20239.80M3.34M51.74%
Jun 30, 20226.46M3.26M102.06%
Jun 30, 20213.20M407.65K14.62%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
CSL Limited23.73B
Pro Medicus212.98M
Cochlear2.34B
Sonic Healthcare9.65B
Ramsay Health Care17.79B
Telix Pharmaceuticals1.01B
Ansell3.06B
Mesoblast26.23M
Revenue Rankings

Clarity Pharmaceuticals News

More News